PhaseIIGoodClinicalPractice(GCP)Follow-up VisitInformedConsentEligibilityCriteriaProtocolData SafetyMonitoringBoard(DSMB)PrincipalInvestigatorTrialRegistryParallelStudyAuditTrailSurrogateEndpointClinicalEndpointCaseReportForm(CRF)Double-BlindStudySourceDataVerificationAdaptiveDesignOpen-LabelTrialTrialMonitorPhaseIRegulatoryAuthorityBlindingEfficacyPlaceboRecruitmentTargetStandardOperatingProcedure(SOP)MulticenterTrialDropoutRatePhaseIIIPatientRecruitmentInterventionProtocolDeviationAdverseEventPilotStudyRandomizationEndpointCrossoverStudyEthicsCommitteeClinicalStudyReport(CSR)DataManagementDataLockSafetyProfileControlGroupInstitutionalReviewBoard(IRB)ScreeningVisitSponsorClinicalResearchCoordinatorInvestigatorMeetingPhaseIVStatisticalAnalysisPlan(SAP)PhaseIIGoodClinicalPractice(GCP)Follow-up VisitInformedConsentEligibilityCriteriaProtocolData SafetyMonitoringBoard(DSMB)PrincipalInvestigatorTrialRegistryParallelStudyAuditTrailSurrogateEndpointClinicalEndpointCaseReportForm(CRF)Double-BlindStudySourceDataVerificationAdaptiveDesignOpen-LabelTrialTrialMonitorPhaseIRegulatoryAuthorityBlindingEfficacyPlaceboRecruitmentTargetStandardOperatingProcedure(SOP)MulticenterTrialDropoutRatePhaseIIIPatientRecruitmentInterventionProtocolDeviationAdverseEventPilotStudyRandomizationEndpointCrossoverStudyEthicsCommitteeClinicalStudyReport(CSR)DataManagementDataLockSafetyProfileControlGroupInstitutionalReviewBoard(IRB)ScreeningVisitSponsorClinicalResearchCoordinatorInvestigatorMeetingPhaseIVStatisticalAnalysisPlan(SAP)

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Phase II
  2. Good Clinical Practice (GCP)
  3. Follow-up Visit
  4. Informed Consent
  5. Eligibility Criteria
  6. Protocol
  7. Data Safety Monitoring Board (DSMB)
  8. Principal Investigator
  9. Trial Registry
  10. Parallel Study
  11. Audit Trail
  12. Surrogate Endpoint
  13. Clinical Endpoint
  14. Case Report Form (CRF)
  15. Double-Blind Study
  16. Source Data Verification
  17. Adaptive Design
  18. Open-Label Trial
  19. Trial Monitor
  20. Phase I
  21. Regulatory Authority
  22. Blinding
  23. Efficacy
  24. Placebo
  25. Recruitment Target
  26. Standard Operating Procedure (SOP)
  27. Multicenter Trial
  28. Dropout Rate
  29. Phase III
  30. Patient Recruitment
  31. Intervention
  32. Protocol Deviation
  33. Adverse Event
  34. Pilot Study
  35. Randomization
  36. Endpoint
  37. Crossover Study
  38. Ethics Committee
  39. Clinical Study Report (CSR)
  40. Data Management
  41. Data Lock
  42. Safety Profile
  43. Control Group
  44. Institutional Review Board (IRB)
  45. Screening Visit
  46. Sponsor
  47. Clinical Research Coordinator
  48. Investigator Meeting
  49. Phase IV
  50. Statistical Analysis Plan (SAP)